CD28 and myeloid sarcoma: In CD4+ T cells from MS patients, miR-17-5p was found to be upregulated and associated with a corresponding downregulation of its target genes, including PTEN, upon stimulation with anti-CD3/CD28 monoclonal antibodies [37].